COSCIENS Biopharma Inc. CSCI
2.72 USD 0.00 (+0.00%)
At closeJul 7, 2026, 4:00 PM EDT
2.72 Day range 2.72
2.50 52-week range 11.10
- YTD
- +33.99%
- 1 year
- +33.99%
News
globenewswire.com COSCIENS ANNOUNCES NEW CORPORATE PRESENTATION AND PROVIDES UPDATE ON CONVERTIBLE DEBENTURE OFFERING TORONTO, ONTARIO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) is pleased to announce the publication of a new corporate…
globenewswire.com COSCIENS COMPLETES SECOND TRANCHE OF CONVERTIBLE DEBENTURE OFFERING TORONTO, ONTARIO, Sept. 16, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) is pleased to announce, further to the press release dated…
accessnewswire.com Brightline Interactive Signs Teaming Agreement with CSCI to Support Unmanned Aircraft and eVTOLs for LIFTOff Louisiana, a Test Site Under the FAA eIPP The partnership potentially positions Brightline's flagship SpatialCore platform for its first civilian government application, as the proposed data infrastructure for testing advanced air mobility…
globenewswire.com COSCIENS Biopharma Inc. Reports Q2 2026 Results TORONTO, ONTARIO, Aug. 11, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCI.F) (“COSCIENS” or the “Company”) today reported its financial and operating results for the second…
globenewswire.com COSCIENS Biopharma Inc. Completes Share Capital Amendment TORONTO, ONTARIO, July 03, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”), today announced the previously announced consolidation (the…
globenewswire.com COSCIENS Biopharma Inc. Announces Details of Share Capital Amendment TORONTO, ONTARIO, June 22, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) announced the next steps in connection with changes to the…
globenewswire.com COSCIENS Biopharma Inc. Announces Results of Shareholder Meeting and Appointment of Full-Time CEO TORONTO, ONTARIO, June 18, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) announced the results from its annual general and special meeting…
businesswire.com CSCI Leverages Technology, Workforce Expansion, and Operational Discipline to Drive Continued Growth Across Florida BOYNTON BEACH, Fla.--(BUSINESS WIRE)-- #BuildingFlorida--CSCI drives continued Florida growth through expanded market share, technology innovation, workforce expansion, and record housing starts.
globenewswire.com COSCIENS Biopharma Inc. Reports Q1 2026 Results TORONTO, ONTARIO, May 12, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) today reported its financial and operating results for the first…
globenewswire.com COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations TORONTO, ONTARIO, April 20, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) announced today that it has filed a Rule 13e-3 Transaction…
globenewswire.com COSCIENS Comments on Unusual Market Activity TORONTO, ONTARIO, April 07, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) is issuing this news release in response to unusual market…
globenewswire.com COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update TORONTO, ONTARIO, March 25, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”), a life science company focused on the development of natural,…
globenewswire.com COSCIENS Provides Strategic Update TORONTO, ONTARIO, March 05, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”) today announced that the Company has made a strategic decision to…
businesswire.com Meet CSCI: The First Family of Florida Shell Construction BOYNTON BEACH, Fla.--(BUSINESS WIRE)--Inside CSCI's Multi-Generational Workforce and the Family-Driven Culture Behind Florida's Fast-Growing Shell Construction Leader.
globenewswire.com COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore TORONTO, ONTARIO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”), a life sciences company focused on pharmaceutical therapies,…
businesswire.com Fueled by Precision and Performance, President Daniel Goldburg Leads CSCI Into Its Next Chapter as Florida's Premier Structural Shell Contractor BOYNTON BEACH, Fla.--(BUSINESS WIRE)--CSCI, one of Florida's pre-eminent structural shell contractors, reports market growth as President Daniel Goldburg leads the firm into the next era.
globenewswire.com COSCIENS Biopharma Inc. Announces Leadership Change TORONTO, ONTARIO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”), a life science company focused on natural ingredients and…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session 
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session 
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session 
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
globenewswire.com COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update COSCIENS Board of Directors approves a plan to voluntarily delist from Nasdaq , while retaining the Company's listing on the TSX
globenewswire.com COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders TORONTO, ONTARIO, June 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) (“COSCIENS” or the “Company”), a life sciences company developing and commercializing a…
globenewswire.com COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders TORONTO, ONTARIO, May 26, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life sciences company developing and commercializing a…- benzinga.com S&P 500 Edges Higher; American Woodmark Shares Slide
benzinga.com Crude Oil Dips; Addex Therapeutics Shares Spike Higher 
benzinga.com US Stocks Mixed; ScanSource Reports Weak Q4 Results 
benzinga.com Why Greenland Technologies Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket